Blend Labs, Inc.
BLND · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.31 | 0.04 | -0.00 | -0.08 |
| FCF Yield | -2.14% | -20.50% | -57.09% | -7.65% |
| EV / EBITDA | -20.77 | -5.20 | -0.61 | -9.35 |
| Quality | ||||
| ROIC | -34.28% | -85.30% | -69.15% | -15.13% |
| Gross Margin | 55.88% | 51.73% | 38.12% | 49.46% |
| Cash Conversion Ratio | 0.30 | 0.71 | 0.25 | 0.75 |
| Growth | ||||
| Revenue 3-Year CAGR | -11.68% | -12.55% | 34.80% | 66.64% |
| Free Cash Flow Growth | 82.15% | 33.39% | -48.76% | -95.06% |
| Safety | ||||
| Net Debt / EBITDA | 0.77 | -0.83 | -0.15 | -0.11 |
| Interest Coverage | -7.35 | -5.07 | -11.34 | -17.49 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 32.50 | 35.94 | 34.04 | 42.41 |